These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 17102615

  • 1. A stronger DNA damage-induced G2 checkpoint due to over-activated CHK1 in the absence of PARP-1.
    Lu HR, Wang X, Wang Y.
    Cell Cycle; 2006 Oct; 5(20):2364-70. PubMed ID: 17102615
    [Abstract] [Full Text] [Related]

  • 2. Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition.
    Horton JK, Stefanick DF, Zeng JY, Carrozza MJ, Wilson SH.
    DNA Repair (Amst); 2011 Feb 07; 10(2):225-34. PubMed ID: 21130714
    [Abstract] [Full Text] [Related]

  • 3. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Luo Q, Li Y, Deng J, Zhang Z.
    Chem Biol Interact; 2015 Jan 25; 226():12-22. PubMed ID: 25499136
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE, Helleday T.
    Nucleic Acids Res; 2006 Jan 25; 34(6):1685-91. PubMed ID: 16556909
    [Abstract] [Full Text] [Related]

  • 5. Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.
    Heacock ML, Stefanick DF, Horton JK, Wilson SH.
    DNA Repair (Amst); 2010 Aug 05; 9(8):929-36. PubMed ID: 20573551
    [Abstract] [Full Text] [Related]

  • 6. Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
    Soni A, Siemann M, Grabos M, Murmann T, Pantelias GE, Iliakis G.
    Nucleic Acids Res; 2014 Jun 05; 42(10):6380-92. PubMed ID: 24748665
    [Abstract] [Full Text] [Related]

  • 7. Ku affects the CHK1-dependent G(2) checkpoint after ionizing radiation.
    Wang X, Li GC, Iliakis G, Wang Y.
    Cancer Res; 2002 Nov 01; 62(21):6031-4. PubMed ID: 12414624
    [Abstract] [Full Text] [Related]

  • 8. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
    Horton JK, Stefanick DF, Gassman NR, Williams JG, Gabel SA, Cuneo MJ, Prasad R, Kedar PS, Derose EF, Hou EW, London RE, Wilson SH.
    DNA Repair (Amst); 2013 Sep 01; 12(9):774-85. PubMed ID: 23871146
    [Abstract] [Full Text] [Related]

  • 9. The Ku-dependent non-homologous end-joining but not other repair pathway is inhibited by high linear energy transfer ionizing radiation.
    Wang H, Wang X, Zhang P, Wang Y.
    DNA Repair (Amst); 2008 May 03; 7(5):725-33. PubMed ID: 18325854
    [Abstract] [Full Text] [Related]

  • 10. Poly(ADP-Ribose) polymerase-1 and DNA-dependent protein kinase have equivalent roles in double strand break repair following ionizing radiation.
    Mitchell J, Smith GC, Curtin NJ.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1520-7. PubMed ID: 19931734
    [Abstract] [Full Text] [Related]

  • 11. Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure.
    Horton JK, Stefanick DF, Naron JM, Kedar PS, Wilson SH.
    J Biol Chem; 2005 Apr 22; 280(16):15773-85. PubMed ID: 15701627
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.
    Godon C, Cordelières FP, Biard D, Giocanti N, Mégnin-Chanet F, Hall J, Favaudon V.
    Nucleic Acids Res; 2008 Aug 22; 36(13):4454-64. PubMed ID: 18603595
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.